Investigating the effect of progressive muscle relaxation on the level of anxiety and vital signs of hospitalized elderly.
Conditions
Interventions
Intervention 1: Intervention group: The control group will be monitored and recorded vital signs (blood pressure, heart rate, breathing) at 10-11 am and 17-18 pm on two occasions for 3 consecutive day
Sponsors
Bojnourd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: Age 60 years and above Having at least mild anxiety upon entering the study Consent of the individual to participate in the study Absence of unstable chronic diseases Absence of neurological defects such as (stroke, Parkinson's disease and paralysis) Not taking anti-anxiety drugs Absence of limiting musculoskeletal disorders Absence of severe congenital defects (vision, hearing and mental disorders, etc.) People who have not participated in similar research. Doctor's approval to participate in the study and no other medical restrictions Absence of previously known mental disorder
Exclusion criteria
Exclusion criteria: Unstable chronic diseases Neurological defects such as (stroke, Parkinson's disease and paralysis) Taking anti-anxiety drugs Existence of restrictive musculoskeletal disorders Existence of severe congenital defects (vision, hearing and mental disorders, etc.) Participation in similar research Users of anti-anxiety drugs before hospitalization Hospitalization due to complementary treatments and surgery Disinterested in participating in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety score. Timepoint: At the beginning and end of the study. Method of measurement: Beck's anxiety questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of heartbeats. Timepoint: Four times a day for three days before and 20 minutes after the intervention. Method of measurement: Measurement with pulse oximeter.;Blood pressure. Timepoint: Four times a day for three days before and 20 minutes after the intervention. Method of measurement: KD 595 digital easy life blood pressure monitor.;Breathing rate. Timepoint: Four times a day for three days before and 20 minutes after the intervention. Method of measurement: It is counted by the research assistant in one minute. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFateme Khorashadizadeh
Bojnourd University of Medical Sciences
Outcome results
None listed